Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
Recruiting
Observational Study
Cancer
Immunotherapy
Advanced Solid Tumors Cancer
Bladder Cancer
TNBC, Triple Negative Breast Cancer
Colorectal Cancer
DMMR Colorectal Cancer
MSI-H Colorectal Cancer
Endometrial Cancer
Head and Neck Cancer
Kidney Cancer
Liver Cancer
NSCLC (Non-small-cell Lung Cancer)
Skin Cancer
Melanoma (Skin Cancer)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 2,000 (estimated)
- Sponsor
- Elephas · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study will collect tumor specimens with correlated clinical and demographic data from patients who are undergoing a biopsy or similar procedure to obtain tumor tissue as a normal course of their medical management or diagnostic work-up for suspected or confirmed cancer.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Able and willing to provide informed consent for participation
2. Age ≥18 years at time of consent.
3. Have a suspected or confirmed cancer diagnosis that is to be evaluated by means of a biopsy.
4. Subjects who are newly diagnosed or have suspected cancer must be treatment-n…
Contacts
No contact information available.